NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Akribion Therapeutics

Akribion Therapeutics

Private
ZwingenbergHealthcare & Life Scienceshttps://akribion-therapeutics.com/

Last Round

Seed

Feb 4, 2025

Total Funding Raised

$8.32M

Company Overview

Akribion Therapeutics is a biotechnology company that develops a unique, RNA-guided, nuclease-based technology for programmable cell depletion.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicinegene silencingoncology therapeuticsGEiGSbiotech R&Dgene expression-based triggered gene silencingCRISPR-nucleasecancer therapyG-dase Eprogrammable medicinecell-type-specific therapytargeted cancer therapydrug discoverybiopharmanext-gen oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akribion Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Akribion Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Akribion Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 4, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Lukas Linnig

Founder Co-Chief Executive Officer

Founding Team

Michael Krohn

Co-Chief Executive Officer Co-Founder

Founding Team

Akribion Therapeutics Investors

Notable investors and investment history

Akribion Therapeutics investors
InvestorRounds
MP Beteiligungs-GmbHSeed
BMH Beteiligungs-Managementgesellschaft HessenSeed
RV InvestSeed
CARMA FUNDSeed
High-Tech GründerfondsSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2025

    BioTech startup emerges from stealth mode.

  • Feb 4, 2025

    $8.64M raised in Seed round.

View all signals

Akribion Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Akribion Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Akribion Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersZwingenberg
Employee Range16
Year Founded2024
Last FundingFeb 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.